FINWIRES · TerminalLIVE
FINWIRES

$ANIP

7 stories mentioning ANIPUpdated 37d ago

Every FINWIRES story that references ANIP, newest first.

What's the latest news on ANIP?

Sectors

Sector Update: Healthcare Stocks Rise Late Afternoon

Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.6%.The iShares Biotechnology ETF (IBB) climbed 2%.In corporate news, Doximity (DOCS) reported higher fiscal Q1 revenue late Thursday, beating consensus but adjusted earnings missed estimates. On the company's post-earnings conference call, per a FactSet transcript, Chief Executive Jeffrey Tangney said the revenue that Doximity's new AI search tool is generating is 10 times what it costs to run. Doximity shares surged 36%.Pulse Biosciences (PLSE) shares jumped past 9% in Friday trading, a day after the company reported its Q2 results.Neurocrine Biosciences (NBIX) shares gained 2.8% after the company said Friday it has started a phase 1 first-in-human trial of NBIP-1968, an experimental drug for obesity.ANI Pharmaceuticals (ANIP) shares were down 5.9% even after it posted higher Q2 adjusted earnings and net revenue.

$ANIP$DOCS$NBIX$PLSE
Sectors

Sector Update: Healthcare Stocks Advance in Afternoon Trading

Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3%.The iShares Biotechnology ETF (IBB) climbed 1.4%.In corporate news, Neurocrine Biosciences (NBIX) shares gained 2.5% after the company said Friday it has started a phase 1 first-in-human trial of NBIP-1968, an experimental drug for obesity.ANI Pharmaceuticals (ANIP) shares were down 6.2% even after it posted higher Q2 adjusted earnings and net revenue.The US Food and Drug Administration said Friday it issued an emergency use authorization for Elanco Animal Health's (ELAN) CLiK Extra wound spray to prevent New World screwworm infestations in sheep, cattle, goats, swine and several other animal species. Elanco shares were down past 5%.

$ANIP$ELAN$NBIX
Sectors

Sector Update: Healthcare Stocks Mixed Premarket Friday

Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.1% lower and the iShares Biotechnology ETF (IBB) up 1.2%.ANI Pharmaceuticals (ANIP) shares were down nearly 7% even after the company posted higher Q2 adjusted earnings and net revenue.National HealthCare (NHC) stock was up more than 2% after the company reported higher Q2 non-GAAP earnings and net operating revenue.Neurocrine Biosciences (NBIX) shares were up more than 1% after the company said it has started a phase 1 first-in-human trial of NBIP-1968, an experimental drug for obesity.

$ANIP$IBB$NBIX$NHC$XLV
Sectors

Sector Update: Healthcare

Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.1% lower and the iShares Biotechnology ETF (IBB) up 1.2%.ANI Pharmaceuticals (ANIP) shares were down nearly 7% even after the company posted higher Q2 adjusted earnings and net revenue.

$ANIP
Insider Trading

Ani Pharmaceuticals Insider Sold Shares Worth $1,127,120, According to a Recent SEC Filing

Patrick D Walsh, Director, on May 11, 2026, sold 13,973 shares in Ani Pharmaceuticals (ANIP) for $1,127,120. Following the Form 4 filing with the SEC, Walsh has control over a total of 38,432 common shares of the company, with 38,432 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1023024/000172056826000005/xslF345X05/wk-form4_1778718127.xml

$ANIP
Sectors

Sector Update: Healthcare Stocks Steady Pre-Bell Friday

Healthcare stocks were steady pre-bell Friday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) down a slight 0.1%.Grifols (GRFS) stock was up more than 2% after the company posted a higher Q1 adjusted profit.ANI Pharmaceuticals (ANIP) shares were up more than 4% after the company reported higher Q1 adjusted earnings and net revenue, and raised its 2026 outlook.Artiva Biotherapeutics (ARTV) stock was up more than 3% after the company priced its $300 million underwritten offering of common shares and pre-funded warrants.

$ANIP$ARTV$GRFS$IBB$XLV
Sectors

Sector Update: Health Care Stocks Lean Lower Premarket Monday

Health care stocks were leaning lower premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) declining by 0.4% and the iShares Biotechnology ETF (IBB) down 0.5%.Biogen (BIIB) has agreed to acquire TJ Biopharma's rights to the felzartamab antibody in the Greater China Region under a definitive agreement, the companies said. Biogen shares were up more than 1% pre-bell.AstraZeneca (AZN) said its pivotal phase 3 study of tozorakimab demonstrated a "significant" reduction in the annual rate of moderate-to-severe chronic obstructive pulmonary disease, or COPD, exacerbations in trial participants. Shares of AstraZeneca were down more than 1% premarket.ANI Pharmaceuticals (ANIP) stock was up more than 1% after the company said it has received US Food and Drug Administration approval and launched Pimozide Tablets in 1 mg and 2 mg doses, the generic version of Orap, with 180-day Competitive Generic Therapy exclusivity.

$ANIP$AZN$BIIB$IBB$XLV

Track with the FINWIRES app suite

FolioX
FolioX
Track ANIP in your portfolio
WheelAI
WheelAI
Analyze ANIP options with the wheel strategy
StockInsider
StockInsider
See market sentiment on ANIP